跳转至内容
Merck
CN
所有图片(2)

文件

安全信息

RLI1MAG-92K

Millipore

MILLIPLEX® Rat Liver Injury Panel - Toxicity Multiplex Assay

别名:

Luminex® Rat Liver Toxicity Assay, Millipore Rat Liver Toxicity Assay, Rat Liver Injury Multiplex Panel

登录查看公司和协议定价


About This Item

UNSPSC代码:
12161503
eCl@ss:
32161000
NACRES:
NA.84

描述

The analytes available for this multiplex kit are: Liver-type arginase 1 (ARG1), aspartate transaminase 1 (GOT1), α-glutathianone S-transferase (GSTα), sorbitol dehydrogenase (SDH), and 5′-Nucleotidase (5′-NT/CD73).

质量水平

种属反应性

rat

制造商/商品名称

Milliplex®

assay range

accuracy: 77-92%
sensitivity: 0.021-4.038 ng/mL
(MinDC+2SD)

standard curve range: 0.02-15.0 ng/mL
(GSTα)

standard curve range: 0.04-30.0 ng/mL
(5′-NT/CD73)

standard curve range: 0.08-60.0 ng/mL
(GOT1)

standard curve range: 0.10-75.0 ng/mL
(ARG1)

standard curve range: 0.62-450.0 ng/mL
(SDH)

技术

multiplexing: suitable

检测方法

fluorometric (Luminex xMAP)

运输

wet ice

一般描述

The MILLIPLEX® Rat Liver Injury Bead Panel (RLI1MAG-92K) contains all the components necessary to simultaneous quantify the following 5 analytes in serum and plasma samples: Liver-Type Arginase 1 (ARG1)*, Aspartate transaminase 1 (GOT1), α-glutathione S-transferase (GSTα)*, Sorbitol Dehydrogenase (SDH)*, 5′-Nucleotidase/CD73 (5′-NT).

*ARG1, GSTα, and SDH are biomarkers listed in the Predictive Safety Testing Consortium (PSTC) project pipeline which have a strong translational role in drug safety testing.

The MILLIPLEX® portfolio provides a valuable research assay to investigate multiple biomarkers of liver injury in rat serum and plasma samples using the Luminex® xMAP® instrument platform. This kit uses a 96-well format, contains a lyophilized standard cocktail, two quality controls and can measure up to 38 serum or plasma samples in duplicate.

Drug toxicity is the leading cause of acute liver failure in the United States. Patients with liver damage generally display elevated amounts of specific liver proteins in serum; these proteins can serve as biomarkers of drug-related liver toxicity. Monitoring these biomarkers can greatly help clinicians avoid drug-induced liver failure. Performing laboratory tests to characterize the side effects of potential therapeutics is an essential part of drug development. The rat is a leading animal model for these pre-clinical toxicity studies. The search for sensitive, organ-specific toxicity biomarkers is complemented by the development of novel assays to measure these critical analytes. Liver-Type Arginase 1 (ARG1), α-glutathione S-transferase (GSTα), and Sorbitol Dehydrogenase (SDH) are biomarkers listed in the Predictive Safety Testing Consortium (PSTC) project pipeline which have a strong translational role in drug safety testing. Aspartate transaminase 1 (GOT1) and 5′-Nucleotidase / CD73 (5′-NT) are traditional biomarkers recognized by both the Food and Drug Administration (FDA) and its European counterpart, the European Medicines Agency (EMA).

Panel Type: Toxicity

应用

  • Analytes: 5′-Nucleotidase (5′-NT/CD73), Liver-Type Arginase 1 (ARG1), Aspartate transaminase 1 (GOT1), α-Glutathione S-Transferase (GSTα), Sorbitol Dehydrogenase (SDH)
  • Recommended Sample Type: Rat serum and plasma
  • Recommended Sample Dilution: 25 μL per well of 1:25 diluted serum or plasma
  • Assay Run Time: 2 hours at room temperature (20-25°C)
  • Research Category: Toxicity

特点和优势

Design your multiplex kit by choosing available analytes within this panel.

组分

Rat Liver Injury Standard, 1 vial, lyophilized

Rat Liver Injury Quality Control 1, 1 vial, lyophilized

Rat Liver Injury Quality Control 2, 1 vial, lyophilized

Assay Buffer, 1 bottle, 30 mL

Wash Buffer, 10X (0.05% Proclin), 2 bottles, 30 mL ea

Rat Liver Injury Detection Antibodies, 1 bottle, 3.2 mL

Streptavidin-Phycoerythrin, 1 bottle, 3.2 mL

Mixing Bottle, 1 bottle

Sample Plate, 96 well format, 1 plate

2 Foil Plate Sealers

其他说明

Please contact Technical Service for linearity of dilution.
Sensitivity: Please see kit protocol for individual assay sensitivities.

法律信息

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

象形图

Skull and crossbonesEnvironment

警示用语:

Danger

危险分类

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Skin Sens. 1

储存分类代码

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

法规信息

新产品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Nalini Govender et al.
Clinical and experimental reproductive medicine, 48(2), 124-131 (2021-05-25)
Approximately 30% of preeclamptic pregnancies exhibit abnormal liver function tests. We assessed liver injury-associated enzyme levels and circulating transforming growth factor beta (TGF-β) levels in an arginine vasopressin (AVP)-induced pregnant Sprague-Dawley rat model. Pregnant and non-pregnant Sprague-Dawley rats (n=24) received

相关内容

了解多重检测试剂盒——如基于Luminex®微珠多重免疫检测的MILLIPLEX®大鼠肝损伤Panel——如何帮助研究人员同时测量多种肝脏毒性生物标志物和细胞因子,加深对药物性肝损伤过程的认识。

Multiplex assays for hepatotoxic biomarker measurement in drug-induced liver injury research.

Multiplex toxicity assays enable researchers to simultaneously measure multiple toxicity biomarkers of various organs to gain a better understanding of toxicity. Explore how MILLIPLEX® multiplex toxicity assays are advancing research on liver injury, kidney toxicity, genotoxicity, and more.

了解在实验室、伴生和农业动物研究中使用生物标志物多重免疫检测产品的优势,探索MILLIPLEX®多重检测试剂盒在兽医学和动物健康研究方面的应用。

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门